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ABSTRACT
The mainstay of assessing guanosine diphosphate release by the
a-subunit of a heterotrimeric G-protein is the [35S]guanosine 5¢-O-(3-
thiotriphosphate) (GTPgS) radionucleotide-binding assay. This assay
requires separation of protein-bound GTPgS from free GTPgS at multiple
time points followed by quantification via liquid scintillation. The
arduous nature of this assay makes it difficult to quickly characterize
multiple mutants, determine the effects of individual variables (e.g.,
temperature and Mg2+ concentration) on nucleotide exchange, or screen
for small molecule modulators of Ga nucleotide binding/cycling prop-
erties. Here, we describe a robust, homogeneous, fluorescence polari-
zation assay using a red-shifted fluorescent GTPgS probe that can
rapidly determine the rate of GTPgS binding by Ga subunits.
INTRODUCTION
S
even transmembrane-domain G-protein coupled receptors
(GPCRs), along with their associated heterotrimeric G-
proteins (Ga guanosine diphosphate [GDP]/Gb/Gg), serve
to transduce signals from diverse extracellular stimuli,
such as photons, tastants, hormones, and neurotransmitters, to the
intracellular compartment.1–3 Agonist binding to the GPCR elicits
guanine nucleotide exchange factor (GEF) activity, resulting in re-
ceptor-catalyzed release of GDP by Ga and subsequent binding of
guanosine triphosphate (GTP).4 The GTP-bound Ga subunit is the
active signaling species, yet has an intrinsic ability to hydrolyze GTP
back to GDP, which can be accelerated by a family of regulators of
G-protein signaling (RGS proteins5). Historically, both receptor-
catalyzed and spontaneous nucleotide release by Ga subunits has
been measured using the radioactively labeled, nonhydrolyzable
nucleotide [35S]guanosine 5¢-O-(3-thiotriphosphate) (GTPgS).6 These
radionucleotide binding assays typically involve incubation of
[35S]GTPgS with the Ga subunit, followed by vacuum filtration,
buffer washes, membrane dessication, and then quantification of
protein-bound [35S]GTPgS by liquid scintillation.7 While producing
reliable and accurate results, this method is tedious, generates ra-
dioactive waste, and is not easily amenable to automation. The use of
membrane-immobilized scintillation proximity assay (SPA) beads
has allowed several groups to develop high-throughput-screen
(HTS)-compatible [35S]GTPgS assays8–10; however, inherent to the
use of radionucleotides is the generation of unwanted radioactive
waste. In an attempt to develop a nonradioactive, HTS-compatible
GTPgS binding assay, others have reported using an europium-labeled
GTPgS probe either in time-resolved fluorescence resonance energy
transfer (TR-FRET)11–13 or in quenching resonance energy transfer
(QRET).14 The ability to use QRET in a homogenous format (i.e.,
without the need for separation of bound and unbound Eu-GTPgS)
represents an advance over the earlier TR-FRET-based assays.15
Additional, non-lanthanide-based fluorescent GTP analogs have also
led to the establishment of nonradioactive assays to quantify the
nucleotide cycling properties of G-proteins16–18; however, these al-
ternate assays involve monitoring changes in the absolute intensity
of the fluor as its local solvating environment changes upon binding
or hydrolysis events. The need to measure absolute intensity change,
coupled with the use of fluors in the green range, prevents these
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assays from being suitable for screening small molecule libraries for
nucleotide-state modulators.19,20 Advances in plate readers capable of
detecting fluorescence polarization (FP) and the commercial availability
of red-shifted fluorescent-GTP analogs recently allowed Evelyn et al.21
to measure nucleotide exchange by small, Rho-subfamily GTPases us-
ing a BODIPY-Texas Red (TR)-GTPgS (Invitrogen). Here, we describe
using this fluor-labeled GTPgS in a homogenous FP assay for measuring
the rate of spontaneous nucleotide exchange by Ga subunits.
MATERIALS AND METHODS
BODIPY-TR-GTPgS was purchased from Invitrogen and all other
chemicals were purchased from Sigma at the highest quality ob-
tainable. Two human Ga subunits were each separately expressed in
Escherichia coli and purified in their GDP-bound forms by affinity
chromatography exactly as previously described7,19: namely, wild-
type Gail and a double-point-mutant Gai1(R178M/A326S) that we
recently developed to have accelerated spontaneous GDP release and
slowed GTP hydrolysis.7 FP experiments were conducted on the
POLARStar Omega plate reader (BMG Labtech) containing a dichroic
mirror and a dual emission beam splitter to measure fluorescence
intensity parallel (F||) and perpendicular (F\) to the excitation plane.
Samples were excited at 584 nm (excitation filter range of 566–
588 nm) and emission was detected at 630 nm (cutoff – 5 nm). The
photomultiplier tubes were calibrated so that 25 nM TR-GTPgS in
assay buffer (10 mM Tris-HCl pH 7.5, 50 mM NaCl, 10 mM MgCl2, and
0.05% (v/v) NP40 alternative) had a polarization of*35 mP. Polar-
ization was calculated as P¼ (F|| F\)/(F||þ F\) and expressed as
mP (‘‘milliP’’ or 1000*P); fluorescence intensity was calculated as
I¼ F||þ 2F\. Trials were conducted at 268C using Corning Black
Polystyrene 96-well plates (cat# CLS3875; Sigma). Gail was diluted to
500 nM in assay buffer and plated at an initial volume of 180 mL/well.
Experiments were initiated upon addition of 20 mL of 250 nM TR-
GTPgS to each well (25 nM TR-GTPgS final concentration). All ex-
periments were conducted at least in triplicate. Nonlinear regression
was used to fit the data to a single exponential association curve
without constraints to calculate the kobs using Prism version 5.0c
(GraphPad).
To compare results obtained by the FP assay with the traditional
radioactivity-based assay, radionucleotide binding assays were per-
formed in parallel as previously described.22 Briefly, assays were
initiated by addition of [35S]GTPgS to 100 nM wildtype Gai1 or
Gai1(R178M/A326S) mutant, either in assay buffer or in assay buffer
containing 100 mM GTPgS. At indicated time points, aliquots were
filtered by vacuum through nitrocellulose membranes and washed
with ice-cold buffer. Assays were conducted in duplicate and error
bars represent standard error of the mean. Nonspecific binding was
subtracted from all time points. Nonlinear regression and statistical
analyses were performed in Prism version 5.
RESULTS
Using the TR-GTPgS FP assay, observed rates of GTPgS binding
(kobs) were determined to be 0.0013 s
1 (95% CI 0.0011–0.0015 s1)
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Fig. 1. Fluorescence-based Texas Red (TR)-guanosine 5¢-O-(3-thiotriphosphate) (GTPgS) binding assay produces the same results as the
gold-standard, [35S]GTPgS radionucleotide binding assay. (A) Fluorescence polarization (FP) was measured at indicated time intervals upon
addition of 25 nM TR-GTPgS (final concentration) to 500 nM of wildtype Gai1 subunit (- -, light gray), the rate-altered Gai1(R178M/A326S)
mutant (-~-, black), or buffer alone (‘‘blank’’; - -, dark gray), all equilibrated at 268C. FP assays were conducted in triplicate and error bars
represent standard error of the mean. kobs values were 0.0013 s
1 (95% CI 0.0011–0.0015 s1) and 0.0078 s1 (95% CI 0.0063–0.0092 s1)
for wildtype Gai1 and the Gai1(R178M/A326S) mutant, respectively. (B) Fluorescence intensities were calculated from the same assay runs
as shown in panel A by the equation: Intensity¼ F||þ 2 · F\. On the basis of the changes in total intensity (i.e., as subtracted from buffer
only values; - -, dark gray), kobs values for wildtype Gai1 (- -, light gray) and Gai1(R178M/A326S) mutant (-~-, black) were 0.0016 s
1 (95%
CI 0.0015–0.0016 s1) and 0.010 s1 (95% CI 0.009–0.011 s1), respectively. (C) Radionucleotide binding assays were performed as pre-
viously described 22. kobs values from the assay were 0.0019 s
1 (95% CI 0.0015–0.0023 s1) and 0.0090 s1 (95% CI 0.007–0.0100 s1) for
wildtype Gai1 (- -, light gray) and the Gai1(R178M/A326S) mutant (-~-, black), respectively.
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and 0.0078 s1 (95% CI 0.0063–0.0092 s1) for wildtype Gai1 and the
double-mutant Gai1(R178M/A326S), respectively (Fig. 1A); the
greater kobs for the latter Ga subunit is wholly consistent with its
known increased rate of spontaneous GDP release and thus faster GTP
binding.7 The change in total intensity (Fig. 1B) was independently
used to determine the kobs for both Gai1 subunits: rates of GTPgS
binding for wildtype Gai1 and Gai1(R178M/A326S) were determined
to be 0.0016 s1 (95% CI 0.0015–0.0016 s1) and 0.010 s1 (95% CI
0.009–0.011 s1), respectively. Both the FP and fluorescence inten-
sity results are consistent with the data obtained using the [35S]-
GTPgS radionucleotide binding assay (Fig. 1C), performed exactly as
previously described.22 Values of kobs using [
35S]-GTPgS binding
were determined to be 0.0019 s1 (95% CI 0.0015–0.0023 s1) and
0.0090 s1 (95% CI 0.007–0.0100 s1) for wildtype Gai1 and
Gai1(R178M/A326S), respectively. While measuring fluorescence
intensity and FP both allow monitoring of TR-GTPgS binding to an
a-subunit of a heterotrimeric G-protein, measuring FP is considered
superior given that it is a ratiometric measurement and thus less
sensitive to interference from compounds that absorb or fluoresce in
the same spectral region.
To validate the sensitivity of the TR-GTPgS FP assay with respect
to changes in spontaneous GDP release, we used the Gai1 GDP-
binding peptide AGS3Con, derived from the consensus of the 4 Go-
Loco motifs of AGS3 (TMGEEDFFDLLAKSQSKRMDDQRVDLAG;
ref.23) and known to exhibit GDP dissociation inhibitory activity
toward Gai GDP subunits.
24,25 A dramatic decrease in the rate of TR-
GTPgS binding was observed using FP upon addition of 10 mM
AGS3Con peptide to wildtype Gai1, as expected (Fig. 2).
23 The rate of
TR-GTPgS binding decreased from 0.0013 s1 (95% CI 0.0012–
0.0014 s1) for wildtype Gai1 alone, to 0.0004 s
1 (95% CI 0.0003–
0.0005 s1) for Gai1 plus AGS3Con peptide. The addition of a
200-fold excess of nonfluorescent GTPgS was able to compete away
completely any change in FP signal over the indicated time interval
(Fig. 2), indicating that the TR-GTPgS does not bind nonspecificially
to Gai1. To establish that this TR-GTPgS FP assay was not specific to a
single plate reader, we also performed this assay on an EnVision
Alpha HTS plate reader (Perkin-Elmer) and observed similar results
(data not shown).
CONCLUSION
We have described a robust, ‘‘mix-and-measure,’’ fluorescence-
based assay system for measuring GTP binding activity by an
a-subunit of a heterotrimeric G-protein. The TR-GTPgS FP assay
should work universally for any Ga subunit, requires no radioac-
tivity, and produces results consistent with radionucleotide bind-
ing assays. For researchers without the ability or desire to use
radionucleotide binding assays, the TR-GTPgS FP assay offers a
safer alternative. Additionally, performing this assay with the
96-well plate reader offers the advantage of automation (e.g.,
screening chemical libraries, profiling hits, and performing these
assays on multiple Ga isoforms or multiple Ga point mutants). On
the basis of its ability to detect differences in the rates of sponta-
neous GDP release by wildtype Gai1 versus the Gai1(R178M/A326S)
mutant, we expect this assay to be readily utilized in assessing
the GEF activity of GPCRs and nonreceptor Ga-GEFs such as Arr4
and RIC-8.26,27
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